Rentschler Biopharma

OverviewSuggest Edit

Rentschler Biopharma is a contract development and manufacturing organization focused on biopharmaceuticals. It specializes in mammalian expression.
TypePrivate
Founded1927
HQLaupheim, DE
Websiterentschler-biopharma.com
Employee Ratings2.7

Latest Updates

Employees (est.) (Jul 2021)451(+3%)
Cybersecurity ratingAMore

Key People/Management at Rentschler Biopharma

Frank Mathias

Frank Mathias

Chief Executive Officer
Alexander Dettmer

Alexander Dettmer

Chief Financial Officer
Show more

Rentschler Biopharma Office Locations

Rentschler Biopharma has offices in Laupheim and Milford
Laupheim, DE (HQ)
Erwin-Rentschler-Straße 21
Milford, MA, US
27 Maple St
Show all (2)

Rentschler Biopharma Financials and Metrics

Summary Metrics

Founding Date

1927

Rentschler Biopharma total Funding

$1.6 m

Rentschler Biopharma latest funding size

$1.6 m

Time since last funding

5 years ago

Rentschler Biopharma investors

Rentschler Biopharma's latest funding round in May 2016 was reported to be $1.6 m. In total, Rentschler Biopharma has raised $1.6 m
Show all financial metrics

Rentschler Biopharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Rentschler Biopharma Online and Social Media Presence

Embed Graph

Rentschler Biopharma News and Updates

Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Martin Kessler as Chief Executive Officer (CEO) of Rentschler…

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

LAUPHEIM, Germany and MARTINSRIED, Germany, and MILFORD, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Leukocare AG, a German biotechnology company specialized in the field …

Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

LAUPHEIM, Germany and STEVENAGE, United Kingdom, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that the Company is establishing a Center of Excellence for cell and gene …

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

LONDON and LAUPHEIM, Germany, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence in innovation advancing the UK’s cell and gene therapy industry, and Rentschler Biopharma SE, a leading global contract development and manufacturi…

Rentschler Biopharma Frequently Asked Questions

  • When was Rentschler Biopharma founded?

    Rentschler Biopharma was founded in 1927.

  • Who are Rentschler Biopharma key executives?

    Rentschler Biopharma's key executives are Frank Mathias and Alexander Dettmer.

  • How many employees does Rentschler Biopharma have?

    Rentschler Biopharma has 451 employees.

  • Who are Rentschler Biopharma competitors?

    Competitors of Rentschler Biopharma include Vetter Pharma, Cyprotex and Vivotecnia.

  • Where is Rentschler Biopharma headquarters?

    Rentschler Biopharma headquarters is located at Erwin-Rentschler-Straße 21, Laupheim.

  • Where are Rentschler Biopharma offices?

    Rentschler Biopharma has offices in Laupheim and Milford.

  • How many offices does Rentschler Biopharma have?

    Rentschler Biopharma has 2 offices.